Robuta

Sponsor of the Day: Jerkmate
https://www.honeywell.com/us/en/press/2025/05/honeywell-to-acquire-johnson-matthey-s-catalyst-technologies-business-expanding-portfolio-of-leading-catalyst-and-process-technologies Honeywell to Acquire Johnson Matthey's Catalyst Technologies Business, Expanding Portfolio of... Honeywell announced that it has agreed to acquire Johnson Matthey's Catalyst Technologies business segment for £1.8 billion in an all-cash transaction,... johnson mattheycatalyst technologiesexpanding portfoliohoneywellacquire https://www.khaleejtimes.com/kt-network/sab-acquires-best-startup-story-bss-expanding-portfolio-and-empowering-entrepreneurship SAB acquires Best Startup Story (BSS), expanding portfolio and empowering entrepreneurship |... Jul 19, 2023 - This strategic acquisition further enhances SAB's portfolio and strengthens its commitment to empowering entrepreneurship in the region best startupexpanding portfolioempowering entrepreneurshipsabacquires https://www.digitaljournal.com/pr/news/prodigy-press-wire/industry-private-capital-acquires-k9-1433912455.html Industry Private Capital Acquires K9 Krunch, Expanding Portfolio of Cash-Generating Consumer Brands industry privatecapital acquiresexpanding portfolioconsumer brandsk9 https://news.lenovo.com/pressroom/press-releases/lenovo-completes-acquisition-of-infinidat-expanding-enterprise-storage-portfolio-enhancing-ai-driven-data-infrastructure/ Lenovo Completes Acquisition of Infinidat: Expanding Enterprise Storage Portfolio and Enhancing... Lenovo announces it has completed the acquisition of Infinidat, a global provider of high-end enterprise storage solutions. completes acquisitionexpanding enterpriselenovoinfinidatstorage https://www.prnewswire.com/news-releases/neurocrine-to-acquire-soleno-therapeutics-expanding-its-endocrinology-and-rare-disease-portfolio-302734531.html Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio Apr 6, 2026 - VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy... soleno therapeuticsrare diseaseneurocrineacquireexpanding https://gamerant.com/opencritic-valnet-acquisition/ Valnet Inc. Acquires OpenCritic.com, Expanding Gaming Portfolio with Leading Review Aggregation... Jul 31, 2024 - OpenCritic Joins the Valnet Gaming Portfolio. inc acquiresvalnetopencriticexpandinggaming